Epidemiology of Behçet's disease in Asian countries and Japan

Advances in Experimental Medicine and Biology

Volumn 528, Issue , 2003, Pages 25-29

  Kaneko, Fumio ^a   Nakamura, Koichiro ^a   Sato, Masataka ^a   Tojo, Michiko ^a   Zheng, Xueyi ^a   Zhang, Jian Zhong ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIINFLAMMATORY AGENT; CYCLOSPORIN A; IMMUNOMODULATING AGENT; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ASIAN; BEHCET DISEASE; EYE INJURY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; NEUROLOGIC DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; AGE DISTRIBUTION; ARTICLE; ASIA; CHINA; FEMALE; MALE; SOUTHERN EUROPE;

AGE DISTRIBUTION; ASIA; BEHCET SYNDROME; CHINA; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; MEDITERRANEAN REGION; PREVALENCE;

EID: 0642308162     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (11)

1. Ohno, S., 1986, Behçet's disease in the world. In Recent Advances in Behçet's Disease (T. Lehner, and C.G. Barnes, eds.), Royal Society of Medicine Services, London, pp. 181-186.
2. Ohno, S., Ohguchi, M., Hirose, S., et al., 1982, Close association of HLA-Bw51 with Behçet's disease. Arch. Ophthalmol. 100: 1455-1458.
3. Zouboulis, Ch.C., 2000, Epidemiology of Adamantiades-Behçet's disease. In Behçet's Disease (D. Bang, E.-S. Lee, and S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 43-47.
4. Jiang, M., Zhijie, Z., and Shiyan, C., 1998, Behçet's disease (in Chinese), In Textbook of Rheumatology (M. Jiang, L. Lhu, and X. Zhou, eds.), Science Press, Beijing, pp. 1219-1220.
5. Chung, Y.L., Bang, D., Lee, E.-S., et al., 2000, Behçet's disease: the first mongolian case in literature showing HLA-51, MICA gene type 5/6. In Behçet's Disease (D. Bang, E.-S. Lee, and S. Lee, eds.), Design Mecca Publishing, Seoul, pp. 98-100.
6. Bang, D., Yoon, K.H., Chung, Y.H., et al., 2000, Epidemiological and clinical features of Behçet's disease. In Behçet's Disease - A Guide to its Clinical Understanding (S. Lee, D. Bang, E.-S. Lee, and S. Sohn, eds.), Springer, Berlin, pp. 177-185.
7. Tan, E., Chua, S.H., and Lim, J.T.E., 1999, Retrospective study of Behçet's disease seen at the National Skin Centre, Singapore. Ann. Acad. Med. Singapore 28: 440-444.
8. Mizushima, Y., Inaba, G., Mimura, Y., et al., 1987, Diagnostic criteria for Behçet's disease in 1987, and guide line for treating Behçet's disease (in Japanese). Saishin Igaku 43: 391-393.
9. Nagai, M., Fuchigami, H., Nishina, M., et al., 2000, Statistics of patients with intractable diseases receiving financial aid for treatment (in Japanese). In Results of Basic Analysis (Research Committee on Epidemiology of Intractable Deseases, Ministry of Health and Welfare, ed.), Japan Government, Tokyo, pp. 64-69.
10. Lee, S., Bang, D., Lee, E-S., et al., 2001, Clinical manifestations. In Behçet's Disease - A Guide to its Clinical Understanding (S. Lee, D. Bang, E.-S. Lee, and S. Sohn, eds.), Springer, Berlin, pp. 19-50.
11. Nishimori, M., Fukuhara, S., Kotake, S., et al., 2002, Cyclosporin therapy and nervous system involvement in patients with Behçet's disease. In Reports of the Research Group of Behçet's Disease (S. Ohno, ed.), Japanese Ministry of Health, Welfare and Labor, Tokyo, pp. 121-127.